The Joint Blog

NOVEMBER 8, 2020

We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system.”. mg/mL of THC and 0.51

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

Cannabis Law Report

OCTOBER 6, 2021

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. Public Relations: Cassandra Dowell. +1 Investor Relations: Evan Veryard. 1 (858) 264-6600.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

AUGUST 5, 2021

Thanks to the license, Filament will look to create the first-ever natural pharmaceutical grade extracts and put them into clinical trials in order to demonstrate safety and efficacy. Filament Health notches patent. Investment summary.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 3, 2021

Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.

Clinical Trials 230

Clinical Trials Legislation DEA Strains 230

NORML

MARCH 30, 2020

By contrast, they reported that there exists “no evidence from properly designed clinical trials to support the use of CBD for the treatment” of these or other conditions, such as the flu, West Nile virus, Ebola, or common cold viruses. However, this data was based solely on preclinical findings.

CBD 295

CBD Clinical Trials Data Treatment 295

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

AUGUST 7, 2021

About MAPS Public Benefit Corporation (MAPS PBC). The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Founded in 2014, MAPS PBC is a Public Benefit Corporation that prioritizes public benefit over profit.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

JANUARY 6, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announced today that it has appointed Scott L. Anderson as Head of Investor Relations and Public Relations, effective immediately. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

MAY 28, 2022

We have a personal connection to this work as we all have family members who have suffered from such debilitating conditions and are drawn to the clinical trial successes which bring promise that psychedelics could become efficacious treatments.

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

NORML

APRIL 15, 2019

Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality. According to the program’s current marijuana menu , no available samples contain more than seven percent THC and all samples contain less than one percent CBD.

Hemp 198

Hemp Clinical Trials Marijuana Programs 198

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JULY 28, 2021

This includes First Time in Human (“FTiH”) clinical trials, which are expected to commence in 2022, for the Group’s lead compound OCT461201, a selective cannabinoid receptor type 2 (“CB2”) agonist with initial indications in the areas of post herpetic neuralgia and visceral pain caused by irritable bowel syndrome.

Cannabinoids 105

Cannabinoids Clinical Trials Safety Medicine 105

Cannabis Law Report

FEBRUARY 24, 2022

Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials. The 2013 amendment cut off access to SAP for psychedelic drugs like MDMA and psilocybin, leaving clinical trials as the only vehicle for patients to access psychedelic services.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

Veriheal

FEBRUARY 9, 2023

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. All imaging and behavioral data will be accessible to the public after the study is complete. What Is an MRI?

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

FloridaMarijuana.net

AUGUST 16, 2018

The CDC’s National Center for Chronic Disease Prevention and Health Promotion publication published an article titled “Dementia and Its Implications for Public Health”states that as the global population increases, the prevalence of Dementia will increase dramatically.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

OCTOBER 2, 2021

About MAPS Public Benefit Corporation (MAPS PBC). The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. Founded in 2014, MAPS PBC is a Public Benefit Corporation that prioritizes public benefit over profit.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

JANUARY 14, 2022

The primary sticking block on the Government benches is the need for evidence of cannabis efficacy and, to this end, it is urging drug manufacturers to put forward their cannabis medicines for clinical trials. Read more [link].

Access 52

Access Clinical Trials Patients Cannabis 52

SpeedWeed

AUGUST 11, 2021

Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression, and PTSD,” said Sisley in a press statement. million from the Colorado Department of Public Health and Environment , and was led by the Scottsdale Research Institute. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

NOVEMBER 19, 2021

About MAPS Public Benefit Corporation (MAPS PBC). It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Why work for MAPS Public Benefit Corporation (MAPS PBC)?

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

AUGUST 9, 2021

Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. The PsyIndex extended its move lower over the past week, even as two companies moved to senior stock exchanges. Market Performance. Powered by. CFN Enterprises Inc.

Clinical Trials 105

Clinical Trials Decriminalization Research and Development Treatment 105

NORML

OCTOBER 21, 2019

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. In June of this year, one applicant – the Scottsdale Research Institute – filed a petition in the US Court of Appeals to order the DEA to comply with its 2016 policy.

DEA 104

DEA Cultivation Clinical Trials Policy 104

Cannabis Law Report

JUNE 7, 2021

The PsyIndex moved marginally higher last week as new companies continue to announce plans to go public. Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. May 31, 2021 – June 4, 2021. With the recent launch of the first U.S. Market Performance.

Research and Development 98

Research and Development Clinical Trials Extraction Retail 98

Canna Law Blog

NOVEMBER 10, 2020

Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive. Unlike with many precursor state laws, no institutional review board review is required.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Cannabis Law Report

JUNE 23, 2021

. “The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic rollout programs.”. The listing follows the successful completion of the previously announced reverse takeover of a Canadian public company, 2835517 Ontario Ltd., Celia Morgan).

Clinical Trials 110

Clinical Trials Therapy Research and Development Treatment 110

Veriheal

MAY 3, 2022

If having an MMJ card has adverse impacts on consumption, the public has a right to know; at the same time, the convoluted nature of the research makes it very easy to misinterpret and misunderstand the findings. Clinical Trial Sample Size. a necessary question to address as medical marijuana becomes more accessible.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. In May 2021, we closed an underwritten public offering, including the full exercise of the underwriters’ greenshoe option, and received net cash proceeds of approximately $154.8 Business highlights. million and $3.1

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

NORML

MARCH 1, 2019

.” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.” ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.

DEA 168

DEA Research and Development Clinical Trials Marijuana 168

Canna Law Blog

NOVEMBER 27, 2021

In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S.

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

Cannabis Law Report

JANUARY 6, 2022

Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well tolerated, and may lead to weight loss, an effect that is consistent with CB1 antagonism in the central nervous system. Head of Investor Relations and Public Relations. For further information about Anebulo, please visit www.anebulo.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Business 52

Cannabis Law Report

NOVEMBER 23, 2021

COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we have completed a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

OCTOBER 28, 2021

Psymposia report… O n Sep 23, 2021, Psymposia staff received an email from the personal email account of Mark Haden — the former Executive Director of psychedelic nonprofit MAPS Canada and current Director of Clinical Trials for Psygen Inc. If you’re not interested in receiving these, please unsubscribe to this list below.

Data 52

Data Clinical Trials Events Medicine 52

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52